Skip to content

Ingevity NGVT Increase (Decrease) in Operating Leases

Increase (Decrease) in Operating Leases at other companies

Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-$422K-12.2%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
-$12.84M+55.8%
Matsons logo
MatsonsMATX
-$29.8M+15.1%
Netscout Systems logo
Netscout SystemsNTCT
-$2.56M+13.0%
Paymentus Holdings logo
Paymentus HoldingsPAY
-$647K-7.1%
LifeStance Health Group logo
LifeStance Health GroupLFST
-$9.96M+16.3%

Other financials

Income statement

See full
Revenue$258.0M+4.1%
Gross profit$116.4M+4.0%
Net income$59.8M+192%
EPS (diluted)$1.66+196%

Balance sheet

See full
Cash & equivalents$95.4M+5.0%
Total debt$1.4B-9.0%
Total equity$38.9M-83.4%
Total assets$1.7B-19.7%

Cash flow

See full
Operating cash flow-$2.0M-108%
CapEx$10.3M+3.0%
Free cash flow-$12.3M-180%

Valuation

See full
Market cap$2.53B+73.9%
Enterprise value$3.8B+32.4%
P/S2.1×+0.9×

Profitability

See full
Gross margin39.3%+1.5pp
Net margin-10.6%-4.1pp
FCF margin20.3%+12.6pp

Returns & leverage

See full
Return on equity-93.5%+1.2pp
Debt / equity35.1×+28.7×
Current ratio1.4×-0.6×

Where this comes from

Reported directly by Ingevity in its filing.

Tagged under the XBRL concept ngvt:IncreaseDecreaseInOperatingLeases.

The official record: Ingevity’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ingevity's increase (decrease) in operating leases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ingevity's increase (decrease) in operating leases?
Ingevity (NGVT) reported increase (decrease) in operating leases of $4.1M in Q1 2026.
How has Ingevity's increase (decrease) in operating leases changed year-over-year?
Ingevity's increase (decrease) in operating leases decreased by 22.6% year-over-year, from $5.3M to $4.1M.
What is the long-term trend for Ingevity's increase (decrease) in operating leases?
Over 4 years (2021 to 2025), Ingevity's increase (decrease) in operating leases has grown at a -1.2% compound annual growth rate (CAGR), from $20.5M to $19.5M.
What does increase (decrease) in operating leases mean?
This represents the cash flow impact of changes in operating lease liabilities, reflecting the net effect of new lease obligations versus payments made to settle existing lease debts. It is a key metric for assessing the company's off-balance-sheet financing commitments and their impact on cash flow.